Inovio Pharmaceuticals INO Earnings Call Transcripts

NASDAQ INO
$1.48 +0.02 (+1.72%)
At close: Nov 11, 2026 · 4:00 PM EST
24 earnings calls on file for Inovio Pharmaceuticals, from Q4 2019 to Q2 2026. Each transcript opens in a new tab.
Latest earnings call

Inovio Pharmaceuticals Q2 2026 Earnings Call

Aug 12, 2026 3,596 words · 16 min read
  • Jennie WillsonDirector of Communications
  • Dr. Jacqueline E. SheaPresident and Chief Executive Officer
  • Dr. Michael SumnerChief Medical Officer
  • Steven EggeChief Commercial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Inovio Pharmaceuticals Earnings Call Transcripts

Calls24
LatestAug 12, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2024

Fiscal 2023

Fiscal 2022

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 24 Inovio Pharmaceuticals transcripts Register to get access to Inovio Pharmaceuticals’s earnings call transcripts.